Literature DB >> 16770743

Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease.

Qunxing Ding1, William R Markesbery, Valentina Cecarini, Jeffrey N Keller.   

Abstract

All cells rely on efficient protein synthesis in order to maintain cellular homeostasis. Recent studies from our laboratory indicate that declines in protein synthesis and ribosome function occur in the earliest stage of Alzheimer's disease (AD). Additional studies indicate a potential role for ribosomal RNA oxidation as a potential mediator of decreased protein synthesis in AD. The ribosome is a complex of proteins and nucleic acids that mediates all protein synthesis. At present it is unclear if significant alterations in ribosomal RNA occurs within the ribosome complex during the progression of AD. In this study we examined the amount of ribosomal RNA in the different ribosomal fractions generated from control subjects, individuals with mild cognitive impairment (MCI), and individuals with AD. Studies were conducted in the inferior parietal lobule of each subject. Together, these data demonstrate that during the progression of AD there is a gross decline in the amount of ribosomal RNA within the ribosome complex. Additionally, these studies provide evidence for gross elevations in RNA oxidation within the ribosome complex of MCI and AD. Together, these data strongly suggest a role for RNA alterations within the ribosome as a mediator of decreased protein synthesis in both MCI and AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770743     DOI: 10.1007/s11064-006-9071-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  17 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival.

Authors:  Qunxing Ding; Jennifer J Lewis; Kenneth M Strum; Edgardo Dimayuga; Annadora J Bruce-Keller; Jay C Dunn; Jeffrey N Keller
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

3.  Selective translational control and nonspecific posttranscriptional regulation of ribosomal protein gene expression during development and regeneration of rat liver.

Authors:  R Aloni; D Peleg; O Meyuhas
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.

Authors:  William R Markesbery; Richard J Kryscio; Mark A Lovell; Jason D Morrow
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

5.  Proteasome inhibition induces reversible impairments in protein synthesis.

Authors:  Qunxing Ding; Edgardo Dimayuga; William R Markesbery; Jeffrey N Keller
Journal:  FASEB J       Date:  2006-06       Impact factor: 5.191

6.  Alzheimer's disease-associated reduction of polysomal mRNA translation.

Authors:  N S Langstrom; J P Anderson; H G Lindroos; B Winblad; W C Wallace
Journal:  Brain Res Mol Brain Res       Date:  1989-06

7.  Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.

Authors:  Xu Li; Irina Alafuzoff; Hilkka Soininen; Bengt Winblad; Jin-Jing Pei
Journal:  FEBS J       Date:  2005-08       Impact factor: 5.542

8.  Evidence of increased oxidative damage in subjects with mild cognitive impairment.

Authors:  J N Keller; F A Schmitt; S W Scheff; Q Ding; Q Chen; D A Butterfield; W R Markesbery
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

9.  Aging, memory, and mild cognitive impairment.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E Kokmen; E G Tangelos
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

10.  An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease.

Authors:  Reiko Onuki; Yoshio Bando; Eigo Suyama; Taiichi Katayama; Hiroaki Kawasaki; Tadashi Baba; Masaya Tohyama; Kazunari Taira
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

View more
  56 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

Review 2.  Emerging roles of the neuronal nucleolus.

Authors:  Michal Hetman; Maciej Pietrzak
Journal:  Trends Neurosci       Date:  2012-02-02       Impact factor: 13.837

3.  Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease.

Authors:  M A Bradley; W R Markesbery; M A Lovell
Journal:  Free Radic Biol Med       Date:  2010-02-18       Impact factor: 7.376

Review 4.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

Review 5.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

6.  Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain.

Authors:  Changxing Shao; Shuling Xiong; Guo-Min Li; Liya Gu; Guogen Mao; William R Markesbery; Mark A Lovell
Journal:  Free Radic Biol Med       Date:  2008-06-11       Impact factor: 7.376

Review 7.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 8.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

Review 9.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

10.  Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Authors:  Rudy J Castellani; Akihiko Nunomura; Raj K Rolston; Paula I Moreira; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.